Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
4GWF2ppHta0DEwhY